Jacobson Allan Steven

Avg. Two Year Performance

No purchase track record
36% Avg. Sale Return
17% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return3%13%15%25%36%
Sale Success Rate3 of 73 of 72 of 73 of 74 of 7

Ptc Therapeutics, Inc.

Drugs » Biotechnology

Director:

Holdings: 16.35K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--